Las Vegas Sands
Ticker:
LVS
Primary Sector:
Discretionary/Industrials
Current Stock Price:
$54.84
High/Base/Low Price Projection:
$58/$46/$31
Morgan Stanley's take: "While LVS continues to be the best positioned for the longer-term Macau 'China penetration' / mass market story, the company lacks the near-term catalysts of peers and is most at risk from new competition."
Myriad Genetics
Ticker:
MYGN
Primary Sector:
Healthcare
Current Stock Price:
$34.32
High/Base/Low Price Projection:
$49/$23/$8
Morgan Stanley's take: "Myriad is now transitioning to a more comprehensive 25 gene panel, myRisk, which tests for hereditary risk of various cancers. Discussions with insurance payors suggest myRisk is meeting resistance for coverage as payors worry about the lack of data proving clinical utility for broad genomic testing and costs."
Parker Hannifin
Ticker:
PH
Primary Sector:
Discretionary/Industrials
Current Stock Price:
$113.21
High/Base/Low Price Projection:
$170/$125/$69
Morgan Stanley's take: "Parker is the purest play on global IP growth to be found in the Machinery group, but uncertainty in the ROW outlook makes material acceleration less likely."